BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity

  October 30, 2024

   · 

  5 min read
• Press Releases

  New Insights from LexisNexis Risk Solutions Highlight the Latest Trends for Breast and Colon Cancer Diagnoses and Screenings

  October 30, 2024

   · 

  3 min read
• Press Releases

  FDA Roundup: October 29, 2024

  October 30, 2024

   · 

  4 min read
• Press Releases

  Celltrion presents post hoc analysis of LIBERTY studies of ZYMFENTRA® (infliximab-dyyb) at the American College of Gastroenterology 2024 Annual Scientific Meeting

  October 30, 2024

   · 

  13 min read
• Press Releases

  DaVita Inc. 3rd Quarter 2024 Results

  October 30, 2024

   · 

  44 min read
• Press Releases

  10x Genomics Reports Third Quarter 2024 Financial Results

  October 30, 2024

   · 

  10 min read
• Press Releases

  BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook

  October 30, 2024

   · 

  28 min read
• Press Releases

  GRAIL to Announce Third Quarter 2024 Financial Results

  October 30, 2024

   · 

  1 min read
• Press Releases

  Biomea Fusion Reports Third Quarter 2024 Financial Results and Corporate Highlights

  October 30, 2024

   · 

  10 min read
• Press Releases

  ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024

  October 30, 2024

   · 

  2 min read